Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Gynecological Cancer × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 343 Breast Neoplasms 327 Colorectal Neoplasms 220 Stomach Neoplasms 195 Carcinoma, Hepatocellular 144 Lung Neoplasms 111 Neoplasms 109 Pancreatic Neoplasms 95 Prostatic Neoplasms 89 Ovarian Neoplasms 87 Recurrence 85 Rectal Neoplasms 84 Neoplasm Metastasis 84 Nasopharyngeal Carcinoma 82 Esophageal Squamous Cell Carcinoma 75 Lymphoma, Large B-Cell, Diffuse 72 Esophageal Neoplasms 71 Melanoma 70 Leukemia, Myeloid, Acute 68 Head and Neck Neoplasms 66 Lymphoma 65 Brain Neoplasms 64 Small Cell Lung Carcinoma 63 Squamous Cell Carcinoma of Head and Neck 62 Multiple Myeloma 62 Uterine Cervical Neoplasms 58 Sarcoma 58 Carcinoma, Renal Cell 58 Triple Negative Breast Neoplasms 53 Lymphoma, Non-Hodgkin 49

Interventions

penpulimab 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05028504 2023-12-27

ALTER-GO-020

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown

Gynecological Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡